Blogs about FRX - Stockpickr! Your Source for Stock Ideas

Blogs about FRX

Blogs	Description	Date Updated
Fast Money Recap	Word On The Street WORD VIDEO HERE Chart Of The Day The Chart of the Day was the S&P 500 trading channel. Burnett said if the chart breaks below 1265 it could fall back to the July lows. Guy Adami didn’t agree, but he also doesn’t think the market is going higher. Pete Najarian thinks the two catalysts in the market are oil and the credit crunch. He said bank stocks looked strong today and energy stocks are weak. Macke said commodities are breaking and it’s time for investors to short...	September 03, 2008
Depressed About Stocks? How about Anti-Depression Drug Stocks?	In the United States, approximately 14 million adults per year are affected by depression, and according to the World Health Organization, depression causes the suffering of an estimated 121 million people throughout the world and is expected to become the second leading cause of disability worldwide by the year 2020. With these numbers, the demand for antidepressants is expected to grow significantlyEli Lilly & Co. (LLY) has the eighth best selling drug, Zyprexa, used to treat schizophrenia, an...	April 21, 2008
Fast Money Recap	Word On The StreetWORD VIDEO HERETechnology TradeSome big tech names like Yahoo! (YHOO), Amazon.com (AMZN), Apple Computer (AAPL) and Microsoft (MSFT) are set to report earnings next. What is the trade? Finerman disclosed she has been selling YHOO, but her hedge fund is net long the stock and MSFT. Macke said he's long MSFT and he thinks AMZN will report ok numbers. Adami said he thinks AAPL will crush earnings, but his favorite tech name is Western Digital (WDC). Najarian said watch EMC (EMC) a...	April 18, 2008
Fast Money Recap	Word On The StreetWATCH THE STREET VIDEO HEREIBM Earnings TradeIBM (IBM) is set to report earnings on Wednesday after the market close. What is the trade? Najarian explained that the options market is pricing in a 7% move in the stock. He thinks Intel (INTC) earnings beat bodes well for IBM and he would be a buyer of the stock ahead of the report. Adami mentioned that IBM gets a lot of its revenues from overseas and 75% of revenues come from overseas banks. He pointed out that IBM will do okay a...	April 15, 2008
Beginning of the Second Quarter Portfolio Reshaping	Well, it’s that time again. Time to make a few portfolio swaps. At present I have two placeholder securities, the industrial Spider, and the technology Spider. Those will go, and I may sell one more security, but that’s it. I will use the proceeds to buy 2-4 positions, so that I will end with 34-35 positions. When I run across an idea between quarters, I write it down on a sheet and wait for the next reshaping. Well, here is the list of tickers I came across over the last 3 mon...	April 09, 2008
Pharmaceutical Stocks and their Patent Expiration Drugs	The next two to four years are an important time frame for many pharmaceutical companies. It is when many of the top selling drugs go off patent. Here is a list of the large pharmas with some of their top selling drugs that are set to 'expire'.AstraZeneca plc (AZN) has the cholesterol drug Crestor, which is set to go off patent in the year 2012. This was recently ranked the 42nd best selling drug. They also have the asthma drug, Symbicort, expires the same year. Their Seroquel, an antipsychotic ...	April 06, 2008
Friday's Upgrades and Downgrades	UpgradesImperial Oil (IMO )- BMO Capital Markets Market Perform » Outperform GSI Group (GSIG)- BMO Capital Markets Underperform » Market Perform Illinois Tool (ITW)- UBS Neutral » Buy Parker-Hannifin (PH)- UBS Sell » Neutral Teck Cominco (TCK)- RBC Capital Mkts Sector Perform » Outperform Nalco (NLC)- Credit Suisse Underperform » Neutral Plexus (PLXS)- Credit Suisse Neutral » Outperform Maxwell Tech (MXWL)- JMP Securities Mkt Underperform » Mkt Perform Sothe...	February 29, 2008
Forest Laboratories: Share price displays bullish 'flag' formation	Filed under: Earnings reports, Analyst upgrades and downgrades, Pfizer (PFE), Lilly (Eli) (LLY), Technical Analysis, Stocks to BuyForest Laboratories (NYSE: FRX) develops branded and generic drug products, as well as non-prescription pharmaceuticals. Offerings include Lexapro, for the treatment of depression, Namenda for Alzheimer's disease, Benicar for hypertension, and Campral for the maintenance of alcohol abstinence. Other products include treatments for diaper rash, colic, cystic fibrosis, ...	January 23, 2008
Tomorrow's Stock Trading Radar 10/16	StreetInsider.com Trading Radar Industrial Production is expected at 9:15AM ET with analysts looking for 0.1% Capacity Utilization is expected at 9:15AM ET with analysts looking for 82.1% Forest Labs (NYSE: FRX) is expected to report results before the open Tuesday with analysts looking for EPS of $0.75 and revenues of $932 million. Johnson & Johnson (NYSE: JNJ) is expected to report results before the open Tuesday with analysts looking for EPS of $0.99 and revenues of $14.84 billion...	October 15, 2007
Pre-Market Analyst Calls (July 11, 2007)	ABT started as Outperform at Wachovia.ACL started as Outperform at Wachovia.AGN started as Outperform at Wachovia.ATVI cut to Neutral at JPMorgan.BAS cut to Sector Perform at RBC.BJS cut to Sector Perform at RBC.BOL started as Mkt Perform at Wachovia.BSX started as Mkt Perform at Wachovia.CME cut to Hold at Deutsche Bank.COO started as Mkt Perform at Wachovia.CPB raised to Overweight at JPMorgan.EFX raised to Outperform at JMP Securities.ESS raised to Overweight at Lehman.EW started as Outperfor...	July 11, 2007

Enter search text here: